✦ LIBER ✦

C1 inhibitor: molecular and clinical aspects

✍ Scribed by Cicardi, Marco ;Zingale, Lorenza ;Zanichelli, Andrea ;Pappalardo, Emanuela ;Cicardi, Benedetta

Publisher: Springer
Year: 2005
Tongue: English
Weight: 138 KB
Volume: 27
Category: Article
ISSN: 0344-4325
DOI: 10.1007/s00281-005-0001-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasminogen activator inhibitor 1: Molec

Plasminogen activator inhibitor 1: Molecular aspects and clinical importance

✍ Douglas E. Vaughan 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 784 KB

Antizyme inhibitor 2: molecular, cellula

Antizyme inhibitor 2: molecular, cellular and physiological aspects

✍ Andrés J. López-Contreras; Bruno Ramos-Molina; Asunción Cremades; Rafael Peñafie 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 220 KB

Progressive multifocal leukoencephalopat

Progressive multifocal leukoencephalopathy: clinical and molecular aspects

✍ Eleonora Tavazzi; Martyn K. White; Kamel Khalili 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

## SUMMARY The fatal CNS demyelinating disease, progressive multifocal leukoencephalopathy (PML), is rare and appears to occur almost always as a consequence of immune dysfunction. Thus, it is associated with HIV/AIDS and also as a side effect of certain immunomodulatory monoclonal antibody therapi

Clinical and molecular aspects of nephro

Clinical and molecular aspects of nephropathic cystinosis

✍ Geraldine A. McDowell; Margaret M. Town; William van’t Hoff; W. A. Gahl 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 486 KB

Molecular and clinical aspects of peroxi

Molecular and clinical aspects of peroxisomal diseases

✍ N. Shimozawa 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 226 KB

Chromosome 2q37 deletion: Clinical and m

Chromosome 2q37 deletion: Clinical and molecular aspects

✍ Rena E. Falk; Kari A. Casas 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views